etoposide has been researched along with Mucositis, Oral in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (8.06) | 18.7374 |
| 1990's | 27 (43.55) | 18.2507 |
| 2000's | 19 (30.65) | 29.6817 |
| 2010's | 9 (14.52) | 24.3611 |
| 2020's | 2 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, J; Guo, R; Han, Z; Jiang, F; Pan, B; Shen, B; Shi, L; Song, H; Wang, L; Wang, Q; Wu, Y; Yang, K; Zhao, W; Zhou, G; Zhou, T; Zhou, W; Zhou, X | 1 |
| Adachi, S; Hiramatsu, H; Horikoshi, Y; Kato, I; Kawaguchi, K; Ogura, T; Saida, S; Takachi, T; Takita, J; Umeda, K; Watanabe, K | 1 |
| Bradstock, KF; Collins, M; Cull, G; Di Iulio, J; Enno, A; Hahn, U; Lewis, ID; Link, E; Marlton, P; Schwarer, A; Seymour, JF; Szer, J | 1 |
| Dagis, A; Epstein, J; Forman, SJ; Nguyen, DT; Palmer, J; Shayani, S; Spielberger, R | 1 |
| Balcı, YI; Greenwood, T; Kenar, F; Koçyiğit, A; Özgürler Akpınar, F; Polat, A; Tesi, B; Yalçın, N | 1 |
| Aquino, V; Duerst, R; Graham, M; Moore, T; Morris, C; Morris, J; Neudorf, S; Olsson, B; Rudebeck, M; Shah, AJ | 1 |
| Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vorkurka, S | 1 |
| Cook, G; Crawley, C; Fields, P; Hickling, R; Hunter, A; Mahendra, P; Marcus, R; Peniket, A; Wilson, K | 1 |
| de Bont, ES; Kamps, WA; Koetse, HA; Rings, EH; Stellaard, F; Tissing, WJ; van Vliet, MJ | 1 |
| Apperley, JF; Auner, HW; Contento, A; Ellis, S; Giles, C; Kanfer, EJ; MacDonald, DH; Naresh, K; Pavlů, J; Rahemtulla, A; Szydlo, RM | 1 |
| Bockova, J; Brandejsova, R; Bystricka, E; Chvojkova, I; Mazur, E; Mjartanova, D; Scudlova, J; Streinerova, K; Vasilieva, E; Visokaiova, M; Vitkova, J; Vodickova, M; Vokurka, S; Vrabcova, M | 1 |
| Barzał, J; Gawroński, K; Młot, B; Oborska, S; Rzepecki, P; Szczylik, C; Waśko-Grabowska, A | 1 |
| Forman, S; Liu, A; Palmer, J; Radany, E; Rosenthal, J; Schultheiss, T; Somlo, G; Stein, A; Wong, JY | 1 |
| Baptista, AM; Belfort, P | 1 |
| Andresen, S; Bernhard, L; Bolwell, BJ; Kalaycio, M; Kohuth, J; Kuczkowski, E; Lomax, R; Mendiola, S; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Grigg, AP; Ritchie, DS; Roberts, AW; Shuttleworth, P; Szer, J | 1 |
| Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
| Acquati, M; Ardizzoia, A; Casartelli, C; Fagnani, D; Fusco, O; Giordano, M; Malugani, F; Quattrone, A; Scanni, A; Tagliabue, P; Vergani, C; Visini, M | 1 |
| Avramis, V; Douglas, JG; Felgenhauer, J; Geyer, JR; Hawkins, DS; Holcenberg, J; Loken, MR; Meshinchi, S; Park, JR; Thomson, B | 1 |
| Bocková, J; Bystrická, E; Koza, V; Misaniová, L; Pavlicová, V; Scudlová, J; Valentová, D; Vokurka, S | 1 |
| Sonis, ST | 1 |
| Bensinger, WI; Blazar, B; Cesano, A; Emmanouilides, C; Gentile, T; Isitt, J; Lu, J; Shea, TC; Spielberger, R; Stiff, PJ | 1 |
| Bystrická, E; Koza, V; Misaniová, L; Pavlicová, V; Scudlová, J; Valentová, D; Visokaiová, M; Vokurka, S | 1 |
| Brunetto, AL; Castro, CG; Cruz, LB; Rech, A; Ribeiro, AS; Rosa, LG | 1 |
| Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vokurka, S | 1 |
| Chen, TT; Costanzi, JJ; Livingston, RB; McGavran, M; Mira, JG; Samson, M | 1 |
| Broun, ER; Cornetta, K; Einhorn, LH; Hanna, M; Hromas, R; Kneebone, PH; Loesch, D; Sledge, GW; Sridhara, R | 1 |
| Armitage, JO; Bierman, PJ; Gwilt, P; Kris, E; Vaughan, WP; Vose, J | 1 |
| Coccia, P; Gordon, B; Hodges, E; Ruby, E; Spadinger, A; Stanley, R | 1 |
| Chan, KW; Cole, CH; Davis, JE; Phillips, G; Pritchard, S; Rogers, PC | 1 |
| Bewermeier, P; Hossfeld, DK; Krüger, W; Mross, K; Reifke, J; Stockschläder, M; Zander, A | 1 |
| Ahmed, T; Chun, H; Cook, P; Coombe, N; Corbi, D; Engelking, C; Helson, L; Mittelman, A; Puccio, C; Szalyga, J | 1 |
| Baker, LH; Zalupski, MM | 1 |
| Cheong, SK; Kim, JS; Kim, YH; Lee, JD; Park, JS; Shin, SW | 1 |
| Anderson, PM; Skubitz, KM | 1 |
| Benhamou, E; Bonnay, M; Couanet, D; Hartmann, O; Plantaz, D; Pondarré, C; Valteau-Couanet, D; Vassal, G | 1 |
| Aguilar-Ponce, L; Dueñas-Gonzalez, A; Frias-Mendivil, M; Gallardo-Rincon, D; Lara-Medina, F; Miranda-Lopez, E; Reynoso-Gomez, E; Sobrevilla-Calvo, P; Zinser-Sierra, J | 1 |
| Chen, S; Lee, BC; Miller, AA; Molthrop, DC; Robert, F; Wheeler, RH | 1 |
| Ezoe, A; Kohda, K; Kuga, T; Matsumoto, S; Mochizuki, C; Nakazawa, O; Niitsu, Y; Nobuoka, A; Watanabe, N | 1 |
| Fosså, SD; Herlofson, BB; Norman-Pedersen, K; Redfors, M | 1 |
| Malik, S; Oblon, DJ; Oblon, MB; Paul, SR | 1 |
| Bernstein, SH; Christiansen, N; Devos, A; Eaves, CJ; Ericson, S; Fay, J; Hawkins, K; Herzig, GP; Herzig, R; Kovalsky, M; Lynch, J; Phillips, GL; Rasmussen, H; Reece, D; Stephan, M | 1 |
| Beijnen, JH; Borst, P; Scheffer, GL; Scheper, RJ; van der Valk, M; van der Valk, P; Wijnholds, J | 1 |
| Braess, J; Büchner, T; Fuchs, R; Grote-Metke, A; Hiddemann, W; Hossfeld, DK; Kern, W; Kuse, H; Reichle, A; Wörmann, B | 1 |
| Fried, G; Haim, N; Stein, ME | 1 |
| Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T | 1 |
| Abboud, CN; Constine, LS; DiPersio, JF; Duerst, RE; Horan, JT; Liesveld, JL; Passarell, JA; Raubertas, RF; Senf, ES; Zwetsch, LM | 1 |
| Daugherty, CK; Hallahan, DE; Laport, GF; Larson, RA; Sobecks, RM; Wagner, ND | 1 |
| Ahmed, T; Baskind, P; Darzynkiewicz, Z; Feldman, EJ; Goff, H; Pozzuoli, M; Santos, S; Seiter, K; Traganos, F | 1 |
| Crawford, J; Glaspy, J; Mazanet, R; Ozer, H; Tomita, DK | 1 |
| Becton, DL; Berry, DH; Kletzel, M | 1 |
| Ortlieb, ML; Parkerson, SG; Spitzer, T; Zerbe, MB | 1 |
| Connors, JM; Hoskins, P; Klimo, P; O'Reilly, SE | 1 |
| Anderson, N; Bern, M; Lokich, J; Moore, C | 1 |
| Albertini, M; Saphner, T; Tormey, DC | 1 |
| Anada, E; Fujimura, T; Fujita, H; Haryo, S; Sawasaki, K; Shima, Y; Shiota, S | 1 |
| Bostrom, B; Kersey, JH; Kim, T; Ramsay, NK; Weisdorf, DJ | 1 |
| Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
| de Vries, EG; Koops, HS; Maas, A; Mulder, NH; Mulder, PO; Sleijfer, DT; Splinter, T; van der Geest, S | 1 |
| Bentley, DP; Littlewood, TJ; Smith, AP | 1 |
| Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M | 1 |
| Dalton, RJ; Gerstner, JB; Letendre, L; Levitt, R; Mailliard, JA; Pierre, RV; Therneau, TM | 1 |
36 trial(s) available for etoposide and Mucositis, Oral
| Article | Year |
|---|---|
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial.
Topics: Etoposide; Humans; Hypertension; Lung Neoplasms; Prospective Studies; Proteinuria; Small Cell Lung Carcinoma; Stomatitis | 2023 |
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Fibroblast Growth Factor 7; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomatitis | 2014 |
Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Myeloablative Agonists; Stomatitis; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2016 |
Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mouthwashes; Phytohemagglutinins; Pilot Projects; Placebos; Recombinant Proteins; Stomatitis | 2009 |
Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
Topics: Acute Disease; Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carbohydrates; Cell Death; Child; Child, Preschool; Citrulline; Cytarabine; Daunorubicin; DNA; Enterocytes; Etoposide; Feces; Female; Humans; Infant; Interleukin-8; Intestinal Absorption; Leukemia, Myeloid; Leukocyte L1 Antigen Complex; Male; Mitoxantrone; Models, Biological; Mucositis; Stomatitis | 2009 |
The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cryotherapy; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Prospective Studies; Risk Factors; Stomatitis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2011 |
Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcium Phosphates; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mouthwashes; Multiple Myeloma; Stomatitis; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Liver; Male; Middle Aged; Organs at Risk; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Recurrence; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2013 |
A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Mucous Membrane; Stomatitis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous | 2002 |
Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophagitis; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Premedication; Remission Induction; Stomatitis; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Bone Marrow Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Etoposide; Female; Flow Cytometry; Humans; Idarubicin; Ifosfamide; Infant; Infusions, Intravenous; Leucovorin; Male; Mesna; Methotrexate; Mouth Mucosa; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis; Thioguanine; Treatment Outcome; Vincristine | 2004 |
The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.
Topics: Adult; Aged; Anti-Infective Agents, Local; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Mouth Mucosa; Mouthwashes; Peripheral Blood Stem Cell Transplantation; Povidone-Iodine; Sex Factors; Sodium Chloride; Stomatitis; Transplantation, Autologous | 2005 |
Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Double-Blind Method; Etoposide; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Mouth Mucosa; Radiation Injuries; Severity of Illness Index; Stomatitis; Treatment Outcome; Whole-Body Irradiation | 2005 |
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Deglutition; Dose Fractionation, Radiation; Double-Blind Method; Drinking; Eating; Etoposide; Female; Fibroblast Growth Factor 7; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mouth Mucosa; Quality of Life; Radiotherapy, Adjuvant; Severity of Illness Index; Sleep; Speech; Stomatitis; Surveys and Questionnaires; Time Factors; Treatment Outcome; Whole-Body Irradiation | 2006 |
Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Irinotecan; Low-Level Light Therapy; Male; Methotrexate; Mouth Mucosa; Neoplasms; Nutritional Status; Oral Hygiene; Severity of Illness Index; Stomatitis; Treatment Outcome | 2007 |
Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Random Allocation; Stomatitis; Vincristine | 1984 |
Tandem autotransplantation for the treatment of metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Middle Aged; Mouth Mucosa; Neoplasm Metastasis; Remission Induction; Stomatitis; Transplantation, Autologous | 1995 |
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Mucosa; Recurrence; Remission Induction; Risk Factors; Stomatitis; Survival Analysis | 1995 |
Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Stomatitis | 1994 |
Propantheline prevention of mucositis from etoposide.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Etoposide; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mouth Mucosa; Preoperative Care; Propantheline; Stomatitis | 1993 |
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Sarcoma; Stomatitis; Treatment Outcome | 1995 |
Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diarrhea; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Stomatitis; Survival Rate; Tegafur; Vomiting | 1996 |
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Double-Blind Method; Doxorubicin; Etoposide; Female; Fluorouracil; Glutamine; Humans; Ifosfamide; Male; Neoplasms; Pilot Projects; Placebos; Sarcoma, Kaposi; Stomatitis; Vincristine | 1996 |
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male; Melphalan; Neuroblastoma; Neutropenia; Remission Induction; Salvage Therapy; Stomatitis; Transplantation Conditioning; Vincristine | 1996 |
Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Misoprostol; Mouth Mucosa; Neoplasms; Stomatitis | 1996 |
Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Creatinine; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Mouth Mucosa; Neoplasms; Statistics, Nonparametric; Stomatitis | 1996 |
[Utility of daily oral administration of etoposide in 25 cases of refractory hematological malignancies].
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Stomatitis; Survival Analysis; Vomiting; Waldenstrom Macroglobulinemia | 1997 |
Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation.
Topics: Adult; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cholinergic Antagonists; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Propantheline; Stomatitis; Transplantation Conditioning; Transplantation, Autologous | 1997 |
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemokine CCL3; Chemokine CCL4; Cyclophosphamide; Etoposide; Female; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Macrophage Inflammatory Proteins; Male; Middle Aged; Platelet Count; Stomatitis | 1997 |
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group.
Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neutropenia; Prospective Studies; Recurrence; Stomatitis; Survival Rate | 1998 |
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: a phase II study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Remission Induction; Stomatitis; Time Factors; Treatment Outcome; Vomiting | 2000 |
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine | 2000 |
Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Grouping and Crossmatching; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Etoposide; Graft Survival; Graft vs Host Disease; Humans; Infant; Leukemia; Myeloablative Agonists; Nuclear Family; Recurrence; Stomatitis; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia.
Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Conjunctivitis; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Risk; Stomatitis; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Tretinoin; Ventricular Dysfunction, Left | 2000 |
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Necrosis; Neutropenia; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Stomatitis; Survival Analysis | 1999 |
Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Stomatitis | 1991 |
26 other study(ies) available for etoposide and Mucositis, Oral
| Article | Year |
|---|---|
Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasms; Prognosis; Retrospective Studies; Stomatitis; Transplantation, Autologous; Young Adult | 2020 |
Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Topics: Adolescent; Adult; Etoposide; Female; Fibroblast Growth Factor 7; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Length of Stay; Male; Middle Aged; Parenteral Nutrition, Total; Quality of Life; Retrospective Studies; Stomatitis; Whole-Body Irradiation; Young Adult | 2015 |
A Hemophagocytic Lymphohistiocytosis Case with Newly Defined UNC13D (c.175G>C; p.Ala59Pro) Mutation and a Rare Complication.
Topics: Amino Acid Substitution; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Debridement; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Membrane Proteins; Methotrexate; Mutation, Missense; Nasal Septal Perforation; Opportunistic Infections; Palate, Soft; Point Mutation; Stomatitis | 2015 |
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Length of Stay; Lymphoma, Non-Hodgkin; Male; Medical Audit; Melphalan; Middle Aged; Multiple Myeloma; Prospective Studies; Risk Factors; Stem Cell Transplantation; Stomatitis; Transplantation Conditioning | 2009 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vomiting; Young Adult | 2011 |
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia.
Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult | 2012 |
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Topics: Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Mucosa; Multivariate Analysis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Stomatitis; Transplantation, Autologous | 2002 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Incidence; Male; Melphalan; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Oral Ulcer; Peripheral Blood Stem Cell Transplantation; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Sex Factors; Stomatitis; Transplantation, Autologous | 2006 |
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Medical Audit; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Research Design; Risk Assessment; Risk Factors; Stomatitis; Transplantation Conditioning; Transplantation, Autologous | 2008 |
Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Mouth Mucosa; Neoplasms; Stomatitis; Thiotepa; Whole-Body Irradiation | 1994 |
Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies.
Topics: Adolescent; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Humans; Infant; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Remission Induction; Stomatitis; Survival Rate; Whole-Body Irradiation | 1994 |
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Case-Control Studies; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Male; Mouth Diseases; Mouth Mucosa; Oral Ulcer; Pain; Retrospective Studies; Stomatitis; Surveys and Questionnaires; Testicular Neoplasms; Vincristine | 1997 |
Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Etoposide; Kidney; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Mouth Mucosa; Organophosphorus Compounds; Oropharynx; Seminiferous Tubules; Stomatitis; Testis; Tongue | 1998 |
A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
Topics: Adult; Blood Platelets; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Graft Survival; Graft vs Host Disease; Heart Failure; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mouth Mucosa; Neutrophils; Recurrence; Stomatitis; Survival; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2000 |
Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dermatitis, Exfoliative; Diarrhea; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Stomatitis; Thrombocytopenia; Vincristine | 1992 |
Relationships between oral mucositis and treatment variables in bone marrow transplant patients.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; District of Columbia; Etoposide; Female; Hospitals, University; Humans; Male; Middle Aged; Nursing Assessment; Pilot Projects; Risk Factors; Severity of Illness Index; Stomatitis; Whole-Body Irradiation | 1992 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Procarbazine; Prognosis; Remission Induction; Stomatitis; Survival Rate; Vinblastine; Vincristine | 1991 |
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Evaluation; Etoposide; Female; Floxuridine; Gastrointestinal Neoplasms; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Risk Factors; Stomatitis; Thrombocytopenia | 1991 |
[Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies].
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Mitomycin; Mouthwashes; Stomatitis; Tegafur; Uracil | 1991 |
Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Leukemia, Myeloid, Acute; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preoperative Care; Radiotherapy, High-Energy; Remission Induction; Stomatitis; Whole-Body Irradiation | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Etoposide; Humans; Leukopenia; Male; Mouth Mucosa; Neoplasms, Germ Cell and Embryonal; Stomatitis; Testicular Neoplasms; Thrombocytopenia | 1988 |
High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
Topics: Bone Marrow Diseases; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mouth Mucosa; Podophyllotoxin; Stomatitis; Transplantation, Autologous | 1986 |
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting | 1986 |
Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia.
Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Stomatitis | 1986 |